Back to search

Belgium· BE-AMP-SAM153851-00

Technescan MAG3 1 mg

A 99mtc-technetium-mertiatid product containing betiatide, registered in Belgium by Curium Belgium. The same ATC class is registered in 10 of our 19 countries.

ATC V09CA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTechnescan MAG3 1 mgATCV09CA03REGISTER NO.BE-AMP-SAM153851-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

99mtc-technetium-mertiatid is registered in 10 of 19 countries.

Countries holding a registration under ATC V09CA03 (99mtc-technetium-mertiatid), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

99mtc-technetium-mertiatid · ATC V09CA03

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Betiatide
Manufacturer
Curium Belgium
Country
Belgium (BE)
ATC code
V09CA03
ATC class
99mTc-Technetium-Mertiatid
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3336351

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

99mtc-technetium-mertiatid in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 99mtc-technetium-mertiatid products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Renoscint Mag3, Technescan Mag3
  • Czechia · Renoscint Mag3, Technescan Mag3
  • Germany · Renoscint Mag3, Technescan Mag3
  • Denmark · Renoscint Mag3, Technescan Mag3
  • Spain · Mag3 Radiopharmacy, Mag3 Technescan
  • Finland · Technescan Mag3
  • France · Technescan Mag 3
  • United Kingdom (Northern Ireland) · Renoscan Mag3, Technescan Mag3
  • Greece · Technescan Mag3
  • Hungary · Renoscint Mag3, Technescan Mag3
  • Ireland · Technescan Mag3
  • Italy · Medirenoscint, Technescan Mag3
  • Malta · Renoscint Mag3
  • Netherlands · Technescan Mag3
  • Norway · Technescan Mag3
  • Poland · Renoscint Mag3
  • Portugal · Technescan Mag3
  • Sweden · Technescan Mag3
  • Slovakia · Technescan Mag3

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/08d9edd1-8dd4-45aa-816c-c5e22bd18664
GET /v1/drugs/08d9edd1-8dd4-45aa-816c-c5e22bd18664?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit for radiopharmaceutical preparation",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Technescan MAG3 1 mg",
  "name_fr": "Technescan MAG3 1 mg",
  "name_nl": "Technescan MAG3 1 mg",
  "amp_code": "SAM153851-00",
  "strengths": [
    "1.0000",
    "1.0000",
    "16.9000"
  ],
  "pack_count": 1,
  "substances": [
    "Betiatide",
    "Disodium Tartrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Technetium (99mTc) Mertiatide",
  "authorisation_numbers": [
    "BE153851"
  ]
}

See everything about 99mtc-technetium-mertiatid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.